"10.1371_journal.pone.0098557","plos one","2014-05-22T00:00:00Z","Justin P Williams; Inki Kim; Emma Ito; Wei Shi; Shijun Yue; Lillian L Siu; John Waldron; Brian O'Sullivan; Kenneth W Yip; Fei-Fei Liu","Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea; Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada","Conceived and designed the experiments: JPW IK EI LLS JW BOS FFL. Performed the experiments: JPW IK SY WS. Analyzed the data: JPW IK EI SY WS FFL. Wrote the paper: JPW IK EI LLS JW BOS KWY FFL.","This work was partially funded by a grant from Pfizer Canada Inc. The Dacomitinib used in this study was provided by Pfizer Canada, Inc. and is a Pfizer product. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","05","Justin P Williams","JPW",10,TRUE,7,4,6,8,TRUE,TRUE,FALSE,0,NA,FALSE
